A total of 97 anaerobic bacteria were tested for susceptibility to ampicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid by broth microdilution and disk elution methods, the results of which were compared with those of the reference agar dilution method. With the broth microdilution method, approximately 95% of MICs were within 1 dilution of those of the reference agar method, with a definite (0.6 to 0.7 dilution) trend toward lower MICs. The disk elution test performed satisfactorily, but additional anaerobic isolates resistant to ampicillin-sulbactam and/or amoxicillin-clavulanic acid (currently rare) are needed to assure the predictability of resistance by the disk elution test.
The 2:1 combinations of ampicillin-sulbactam and amoxicillin-clavulanic acid have been shown to have a greater spectrum of antimicrobial activity than ampicillin or amoxicillin alone (2, 7, 9) . This broadened spectrum includes activity against P-lactamase-producing bacteria and is due to the P-lactamase-inhibitory activity of sulbactam and clavulanate (3, 6) . Among the bacteria added to the spectrum are the P-lactamase-producing anaerobes, such as the Bacteroidesfragilis group (1, 8, 9) . Consequently, these drugs are potential therapeutic agents for anaerobic infections, and susceptibility testing may be requested of clinical laboratories. Two common methods of anaerobe susceptibility testing are broth microdilution and disk elution. This study was designed to evaluate these two methods for the testing of susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid by comparing them with the reference agar dilution method.
A total of 97 strains of clinical anaerobic isolates were tested. These isolates included the following: Bacteroides bivius (5 strains), B. distasonis (6 strains), B. fragilis (40 strains), B. melaninogenicus (3 strains), B. ovatus (5 strains), B. thetaiotaomicron (6 strains), B. uniforms (1 strain), B. vulgatus (6 strains), Clostridium bifermentans (2 strains), C. clostridiiforme (1 strain), C. difficile (2 strains), C. perfringens (5 strains), C. ramosum (1 strain), C. sporogenes (2 strains), Eubacterium lentum (3 strains), Peptostreptococcus anaerobius (6 strains) and P. asaccharolyticus (4 strains). One strain (C. ramosum) did not grow in the disk elution medium. Also, one strain of B. melaninogenicus was tested against ampicillin-sulbactam but not against amoxicillin-clavulanic acid.
Ampicillin and sulbactam were supplied as standard powders by Roerig-Pfizer, New York, N.Y.; amoxicillin and clavulanic acid were provided by Beecham Laboratories, Bristol, Tenn. Disks of ampicillin (10 ,ug), ampicillin-sulbactam (10 ,ug/10 ,ug), and amoxicillin-clavulanic acid (20 ,ug/ 10 ,ug) were prepared by Difco Laboratories, Detroit, Mich.
The reference agar dilution susceptibility test was performed in strict accordance with the National Committee for Clinical Laboratory Standards method (4). The concentrations of ampicillin tested were serial twofold dilutions ranging from 32 to 0.5 ,ug/ml. The ampicillin and amoxicillin * Corresponding author.
concentrations in ampicillin-sulbactam and amoxicillin-clavulanic acid, respectively, ranged from 32 to 0.25 ,ug/ml. The concentrations of sulbactam and clavulanate were one-half those of ampicillin and amoxicillin, respectively. Both the broth microdilution and the disk elution tests were performed as outlined by the National Committee for Clinical Laboratory Standards (5 in Table 1 . For both ampicillin and ampicillin-sulbactam, 95% of microdilution endpoints were within 1 dilution of the agar dilution endpoints; this was true for 93% of amoxicillinclavulanic acid endpoints. There was, however, a definite skewing toward slightly lower MICs with the microdilution method for all three drugs. The differences averaged 0.6 dilution for ampicillin and 0.7 dilution for ampicillin-sulbactam and amoxicillin-clavulanic acid, but these differences did not result in any susceptibility category changes and were felt to be of little practical significance. The data comparing the disk elution test results with those of the reference agar dilution test are summarized in Table 2 . For ampicillin, the disk elution test yielded ambivalent results when the agar dilution (or broth microdilution) MICs were near the break point concentrations (8 or 16 ,ug/ml). At each MIC, approximately half of the organisms were susceptible and half were resistant. Among the 55 isolates for which ampicillin MICs were .32 pg/ml, there were two false-susceptible disk elution results. All of the 93 organisms susceptible to ampicillin-sulbactam and the 94 organisms susceptible to amoxicillin-clavulanic acid (MIC, -8.0 ,uglml) were susceptible by the disk elution test as well. There were three organisms for which ampicillin-sulbactam MICs were 16 ,ug/ml (intermediate susceptibility category), two of which were susceptible and one of which was resistant by the disk elution test. There was one isolate that was resistant to amoxicillin-clavulanic acid (MIC, 32 ,ug/ml) by agar dilution, and it was also resistant by disk elution. Because none of the anaerobes tested were resistant to ampicillin-sulbactam and only one was resistant to amoxicillin-clavulanic acid, it was not possible to evaluate the performance of the disk elution test with resistant anaerobes. Anaerobic bacteria resistant to these P-lactamase inhibitor combinations appear to be very rare at present.
We conclude that the broth microdilution test is an acceptable alternative to the reference agar dilution test for the testing of anaerobic susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid. The disk elution test provided reliable results for anaerobes susceptible to ampicillinsulbactam and amoxicillin-clavulanic acid, but since resistant isolates were not available for such studies, no conclusions can be reached about the reliability of this test for anaerobes resistant to these drug combinations.
